Pricing Log in Create free account

Bright Minds Biosciences Inc. (DRUG) vs Puma Biotechnology, Inc. (PBYI)

Bright Minds Biosciences Inc. and Puma Biotechnology, Inc. are both Biotechnology companies. Bright Minds Biosciences Inc. and Puma Biotechnology, Inc. are of similar size ($543.0M and $534.7M). Bright Minds Biosciences Inc. has negative trailing earnings, so its P/E is not meaningful; Puma Biotechnology, Inc. trades at 18.2×. Puma Biotechnology, Inc. has the higher net margin (11.6% vs 0.00%) and the higher return on invested capital (42.6% vs 0.00%). Across the 13 metrics below, Puma Biotechnology, Inc. leads on 11 and Bright Minds Biosciences Inc. on 2.

Valuation

Metric DRUG PBYI Biotechnology median
P/E n/m 18.20 8.50
P/S n/m 2.17 9.71
P/B 2.27 3.61 2.13
Price to free cash flow n/m 17.52 20.82
EV/EBITDA n/m 10.48 0.64
EV/Sales n/m 1.86 9.21
Earnings yield (4.05%) 5.49% (33.15%)
Free cash flow yield (3.52%) 5.71% (25.50%)

Profitability

Metric DRUG PBYI Biotechnology median
Gross margin 0.00% 74.83% 65.16%
Operating margin 0.00% 13.16% 0.00%
Net margin 0.00% 11.55% 0.00%
Free cash flow margin 0.00% 17.79% 0.00%
Return on equity (13.64%) 21.97% (56.36%)
Return on assets (13.52%) 13.78% (48.04%)
Return on invested capital 0.00% 42.61% 0.00%

Growth

Metric DRUG PBYI Biotechnology median
Revenue growth (TTM) — (2.86%) 6.02%
EPS growth (last fiscal year) (164.58%) (1.61%) 30.26%
Revenue growth, 5-year CAGR — 0.29% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DRUG PBYI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 121.98 2.91 4.72
Net debt to EBITDA 5.98 (1.60) 0.96

Dividend

Metric DRUG PBYI Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DRUG PBYI Biotechnology median
Market cap 534.73m 543.04m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack